ORION OYJ |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.53 EUR | +0.14% |
|
+4.19% | +5.76% |
| 07-01 | Orion, Merck & Co. Convert Agreement into Exclusive Global License to Opevesostat | MT |
| 07-01 | Orion Upgrades FY24 Outlook After Modifying Agreement with Merck & Co | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORION OYJ | Other Pharmaceuticals | +0.14% | +4.19% | +5.76% | +10.13% | +23.79% | 6.31B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ORNBV Stock
- Charts Orion Oyj
- Comparison Chart
